In Eswatini, the pregnant women living with hiv antiretroviral therapy coverage for pmtct currently stands at 100%, reflecting an increase of 3% (3.1%) since 2021.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Eswatini
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Eswatini
PMTCT antiretroviral therapy coverage
More indicators for Eswatini
Male unintentional poisoning
4.3
0.0
(2019)
Female wasting in children
1.7%
+0.7%
(2014)
Female prevalence of HIV
11.7%
-1%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar71
+intl dollar7
(2021)
Birth registration
53.5%
+4%
(2014)
Contraceptive modern method prevalence
65.5%
+2.4%
(2014)
Eswatini PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 100% | +3% |
| 2021 | 97% | +8% |
| 2020 | 89% | -11% |
| 2019 | 100% | +6% |
| 2018 | 94% | +14% |
| 2017 | 80% | -7% |
| 2016 | 87% | +3% |
| 2015 | 84% | +7% |
| 2014 | 77% | -7% |
| 2013 | 84% | +1% |
| 2012 | 83% | -2% |
| 2011 | 85% | +16% |
| 2010 | 69% | +2% |
| 2009 | 67% | -4% |
| 2008 | 71% | -2% |
| 2007 | 73% | +1% |
| 2006 | 72% | +57% |
| 2005 | 15% | +6% |
| 2004 | 9% | +7% |
| 2003 | 2% | +1% |
| 2002 | 1% | +1% |
| 2001 | 0% | 0% |
| 2000 | 0% |